“Generic Drug User Fees (GDUFA) – How Do They Impact ANDA Applicants and Type II DMF Holders?”


In this webinar, Prabu Nambiar, Ph.D. MBA, RAC,CMC Consultant to The Weinberg Group Inc., helps life science executives appreciate the value of user fees in an FDA-regulated world